Skip to main content
. 2015 Jan 21;6(8):5832–5845. doi: 10.18632/oncotarget.3332

Figure 2. Effect of afatinib on cell growth in NSCLC PC-9.

Figure 2

(A), PC-9-GR (B), H1975 (C) and H460 (D). Cells were treated with afatinib at indicated concentrations, and cell viabilities were determined using MTS assay. Data represent the average of three experiments. Error bars indicate standard deviation.